Vera Therapeutics, Inc. Stock - MarketScreener.com

Apr 30, 2016 · Certain Options of Vera Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 30-DEC-2024. Dec. 29: CI Certain Class A common stock of Vera Therapeutics, …

3%
OFF

What's Going On With Vera Therapeutics Stock? - Benzinga

1 week from now

3 days ago · Vera Therapeutics Inc VERA shares are trading lower by 7.3% to $34.31 Monday afternoon. The company announced an exclusive license agreement with Stanford University …

benzinga.com

$75.00
OFF

Evercore ISI Sticks To Its Buy Rating For Vera Therapeutics (VERA)

1 week from now

3 days ago · Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vera Therapeutics (VERA – Research Report) today and set a price target of $75.00. The company’s shares …

businessinsider.com

$42.19
OFF

Vera Therapeutics Grants Stock Options And RSUs To Six New

1 week from now

(RTTNews) - Vera Therapeutics ... The stock options have an exercise price of $42.19 per share, which was the closing price on January 8, 2025. The options will vest over four years, with …

nasdaq.com

$753680
OFF

Share Ownership Vera Therapeutics, Inc. - MarketScreener.com

1 week from now

Dec 26, 2024 · Vera Therapeutics Insider Sold Shares Worth $753,680, According to a Recent SEC Filing MT Dec. 15: Certain Class A common stock of Vera Therapeutics, Inc. are subject …

marketscreener.com

FAQs about Vera Therapeutics, Inc. Stock - MarketScreener.com Coupon?

Where is Vera Therapeutics Inc headquartered?

The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA. VERA | Complete Vera Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ...

Who is Vera Therapeutics?

Visit a quote page and your recently viewed tickers will be displayed here. Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA. ...

Should you buy Vera Therapeutics (Vera)?

Currently, the analyst consensus on Vera Therapeutics is a Strong Buy with an average price target of $68.00. VERA market cap is currently $2.34B and has a P/E ratio of -13.38. TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. ...

Does Vera Therapeutics offer inducement Awards?

BRISBANE, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on December 3, 2024, the Compensation Committee granted inducement awards consisting of ... ...

What is Vera's vt-109 agreement?

This agreement will enable Vera to develop and market VT-109 in return for undisclosed upfront and milestone payments. Vera Therapeutics is a late clinical-stage biotechnology company focused on developing treatments for serious immunological diseases. ...

What is Vera's new approach to B cell modulation?

“This novel approach is part of Vera’s broad lifecycle management strategy to expand and extend our leadership position within B cell modulation, which we believe has the potential to transform how we treat patients suffering from a variety of B cell mediated diseases. ...